Phase 3 clinical development of semaglutide (2015-2026): a comprehensive evidence-based review of trial designs, therapeutic outcomes and global clinical experience
Diabetes research and clinical practice · 2026 Nov 7 · Patel SK, Dubey S, Tiwari A et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 6 19:00 ETSource: Diabetes research and clinical practice
From the source
Read at pubmed.ncbi.nlm.nih.govPhase 3 clinical development of semaglutide (2015-2026): a comprehensive evidence-based review of trial designs, therapeutic outcomes and global clinical experience
Diabetes research and clinical practice · 2026 Nov 7 · Patel SK, Dubey S, Tiwari A et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42998725/
